[HTML][HTML] The cytokine network in acute myeloid leukemia

M Luciano, PW Krenn, J Horejs-Hoeck - Frontiers in Immunology, 2022 - frontiersin.org
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

[HTML][HTML] The cytokine network in acute myeloid leukemia

M Luciano, PW Krenn, J Horejs-Hoeck - Frontiers in Immunology, 2022 - frontiersin.org
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

The cytokine network in acute myeloid leukemia

M Luciano, PW Krenn… - Frontiers in …, 2022 - pubmed.ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

The cytokine network in acute myeloid leukemia

M Luciano, PW Krenn… - Frontiers in …, 2022 - uni-salzburg.elsevierpure.com
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

[HTML][HTML] The cytokine network in acute myeloid leukemia

M Luciano, PW Krenn, J Horejs-Hoeck - Frontiers in Immunology, 2022 - ncbi.nlm.nih.gov
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

The cytokine network in acute myeloid leukemia.

M Luciano, PW Krenn, J Horejs-Hoeck - Frontiers in Immunology, 2022 - europepmc.org
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …

The cytokine network in acute myeloid leukemia.

M Luciano, PW Krenn, J Horejs-Hoeck - Frontiers in Immunology, 2022 - europepmc.org
Acute myeloid leukemia (AML) is a highly heterogeneous malignancy of the blood and bone
marrow, characterized by clonal expansion of myeloid stem and progenitor cells and rapid …